Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study
Authors
Keywords
Apolipoprotein B, Cholesterol, Diabetes mellitus, Eicosapentaenoic acid, Hydroxymethylglutaryl-CoA reductase inhibitors, Hypertriglyceridemia, Icosapent ethyl, Low density lipoprotein, Triglycerides
Journal
Cardiovascular Diabetology
Volume 12, Issue 1, Pages 100
Publisher
Springer Nature
Online
2013-07-09
DOI
10.1186/1475-2840-12-100
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
- (2012) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis
- (2012) Jason H. Y. Wu et al. BRITISH JOURNAL OF NUTRITION
- Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart
- (2012) Lianguo Hou et al. Cardiovascular Diabetology
- The Use of ω-3 Poly-Unsaturated Fatty Acids in Heart Failure: A Preferential Role in Patients with Diabetes
- (2012) Pedram Kazemian et al. CARDIOVASCULAR DRUGS AND THERAPY
- Administration of highly purified eicosapentaenoic acid to statin-treated diabetic patients further improves vascular function
- (2012) Junko Sasaki et al. ENDOCRINE JOURNAL
- Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)
- (2012) Harold E. Bays et al. Journal of Clinical Lipidology
- Remnant Cholesterol
- (2012) Ruth McPherson JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Biological Effects of Add-On Eicosapentaenoic Acid Supplementation in Diabetes Mellitus and Co-Morbid Depression: A Randomized Controlled Trial
- (2012) Roel J. T. Mocking et al. PLoS One
- Triglycerides and Cardiovascular Disease
- (2011) Michael Miller et al. CIRCULATION
- Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
- (2011) Melissa Y. Wei et al. Current Atherosclerosis Reports
- n-3 Fatty Acids, Ventricular Arrhythmia-Related Events, and Fatal Myocardial Infarction in Postmyocardial Infarction Patients With Diabetes
- (2011) D. Kromhout et al. DIABETES CARE
- Trends in the Risk for Coronary Heart Disease Among Adults With Diagnosed Diabetes in the U.S.: Findings from the National Health and Nutrition Examination Survey, 1999-2008
- (2011) E. S. Ford DIABETES CARE
- Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review
- (2011) Terry A. Jacobson et al. Journal of Clinical Lipidology
- n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
- (2010) Daan Kromhout et al. NEW ENGLAND JOURNAL OF MEDICINE
- Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)
- (2009) Shinichi Oikawa et al. ATHEROSCLEROSIS
- Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia
- (2009) Michael H. Davidson et al. Journal of Clinical Lipidology
- Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
- (2009) Jennifer G. Robinson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
- (2008) Jean-Charles Fruchart et al. Diabetes & Vascular Disease Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More